Moderna Stock: Everything You Need To Know

Moderna is a biotechnology company founded in Cambridge, Massachusetts, in 2010. 

It focuses on developing messenger RNA (mRNA) therapeutics designed to treat diseases by modifying DNA instructions for cells to create disease-targeting proteins.  

The company has seen significant growth over the last few years and is now worth an estimated $65 billion. 

Moderna stock went public in 2018 and hovered between $15 to $20 till it took off in 2020. When writing this article on January 30, 2022, here are the fundamentals you should pay attention to for Moderna from Yahoo Finance. 

Market Capitalization: $64.657B 

Market capitalization measures the company's worth based on the number of issued shares at the current market share price. 

PE Ratio: 8.9 

The Price to Earnings (PE) ratio is calculated by dividing the current share price by the earnings per share (EPS). This ratio is a measure of how expensive a company's stock is when compared to other companies.